Thie expert commentary discusses potential clinical management strategies for patients who experience psychosis or other breakthrough symptoms during treatment with an LAI antipsychotic considering pharmacologic and psychosocial options while prioritizing the patients agency in their treatment
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/psychiatry/lai-breakthrough-symptoms/25075-63964
- Start Date: 2024-11-27 06:00:00
- End Date: 2024-11-27 06:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 4545.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest